PD-1/PD-L1-IN-9 hydrochloride

• CAT Number: I042371
• Molecular Formula: C22H25ClN2O2
• Molecular Weight: 384.90
• Purity: ≥95%
• Synonyms: 2-[[2-methoxy-6-(2-methyl-3-phenylphenyl)pyridin-3-yl]methylamino]ethanol;hydrochloride
• InChI: InChI=1S/C22H24N2O2.ClH/c1-16-19(17-7-4-3-5-8-17)9-6-10-20(16)21-12-11-18(15-23-13-14-25)22(24-21)26-2;/h3-12,23,25H,13-15H2,1-2H3;1H
• InChIKey: KXEWBOPJWFJJFD-UHFFFAOYSA-N
• SMILES: CC1=C(C=CC=C1C2=NC(=C(C=C2)CNCCO)OC)C3=CC=CC=C3.Cl

PD-1/PD-L1-IN-9 hydrochloride（Cat No.:I042371）is a small molecule inhibitor designed to target the interaction between programmed cell death protein 1 (PD-1) and its ligand, PD-L1. This interaction is a key immune checkpoint that tumors exploit to evade immune detection. By inhibiting PD-1/PD-L1 binding, PD-1/PD-L1-IN-9 hydrochloride aims to enhance the immune response against cancer cells, thereby offering potential therapeutic benefits in cancer immunotherapy. Research is ongoing to evaluate its effectiveness in various cancers, including melanoma, lung cancer, and other malignancies, with the goal of improving immune system activity against tumors.